Evidence map›Paper›PMID 41353523›Full record

ArticleNPJ precision oncology2025

Integration of multi-scale radiomics and deep learning for Ki-67 prediction in clear cell renal carcinoma.

Jinshuai Li, Dingyang Lv, Zhiwei Guo, Huiyu Zhou, Xiaomei Yao, Yi Rong, Xiaodong Bian, Lei Pang, Tiantian Zhao, Ying Qiao and 1 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jinshuai Li *Department of Urology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China.
Dingyang Lv *Department of Urology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China.
Zhiwei Guo *Department of Urology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China.
Huiyu ZhouDepartment of Urology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China.
Xiaomei YaoDepartment of Medical Imaging, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China.
Yi RongDepartment of Urology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China.
Xiaodong BianDepartment of Urology, Shanxi Provincial People's Hospital, No. 82 Shuangta Temple Street, Yingze District, Taiyuan, Shanxi, 030001, China.
Lei PangDepartment of Urology, Shanxi Provincial People's Hospital, No. 82 Shuangta Temple Street, Yingze District, Taiyuan, Shanxi, 030001, China.
Tiantian ZhaoDepartment of Radiology, Shanxi Bethune Hospital, No. 99 Longcheng Avenue, Xiaodian District, Taiyuan, Shanxi, 030032, China.
Ying QiaoDepartment of Medical Imaging, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China. 15103462912@163.com.
Weibing ShuangDepartment of Urology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, 030001, China. shuangweibing@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High Ki-67 expression in clear cell renal cell carcinoma (ccRCC) predicts poor prognosis but requires postoperative assessment. In a multicenter retrospective study of 627 ccRCC patients, we developed and validated a multi-modal model, integrating multi-scale radiomics and deep learning (DL) features, for non-invasive, preoperative Ki-67 prediction. Using ensemble machine learning algorithms, unimodal models were constructed from preoperative CT-derived multi-scale radiomics (intratumoral, habitat, peritumoral), 2D/3D DL, and clinical features. A stacking strategy was used to fuse the best-performing unimodal models. The fusion model demonstrated superior performance, achieving an Area Under the Curve (AUC) of 0.756 (95% CI 0.692-0.821) in the external test set. The model demonstrated excellent calibration and the highest clinical net benefit, with habitat radiomics identified as the dominant predictive component via SHAP analysis. Our validated multi-modal model significantly improves the preoperative prediction of Ki-67 expression compared to unimodal approaches, offering a promising tool to guide individualized surgical and surveillance strategies.

Identifiers

PMID41353523
PMCPMC12783816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.